Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
CHRS
Coherus Oncology, Inc.
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$1.21
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$186.95M
Country
USA
RECENT INSIDER TRADES
2026-06-09
· Newton Charles W.
(Director)
· OTHER
2026-06-09
· O'Donnell-Tormey Jill
(Director)
· OTHER
2026-06-09
· Karachun Rita A
(Director)
· OTHER
2026-06-09
· Newcomer Lee Nisley
(Director)
· OTHER
2026-06-09
· Satvat Ali J.
(Director)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
157
Shares held
92,621,140
Value
$130.09M
Percent of shares outstanding
59.95%
As of quarter end
2026-06-30
RECENT NEWS
Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets
Coherus Oncology presents at Morgan Stanley healthcare conference
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Coherus Oncology, Inc. (CHRS) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit